Voyager Therapeutics
Voyager Therapeutics is hiring a Scientist II, Protein Science to join its Non-Viral Therapeutics Team focused on developing novel biotherapeutics for neurological diseases. The role centers on creating complex protein-based therapeutics such as fusion proteins and bispecific antibodies, working closely with internal discovery and engineering partners. The position supports pipeline programs across multiple CNS indications within a genetics-driven biotechnology company.
Headquarters
Lexington, Massachusetts, United States
Company Size
51-200 employees
Founded
2014
Voyager Therapeutics (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging human genetics to treat and ultimately cure neurological diseases. Their pipeline includes genetic medicines for Alzheimer's disease, ALS, Parkinson's disease, and other CNS conditions, with multiple Alzheimer's programs currently in development. Many of their programs are derived from their proprietary TRACER™ AAV capsid discovery platform, which enables intravenous delivery of gene therapies across the blood-brain barrier.
H.C. Wainwright reiterates Voyager Therapeutics stock rating at buy
12 hours ago
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Voyager Therapeutics (VYGR) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)
14 hours ago
Voyager Therapeutics' (VYGR) "Buy" Rating Reaffirmed at HC Wainwright
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Voyager Therapeutics.
Voyager Therapeutics (VYGR): Analyst Reiterates Buy Rating and M
1 day ago
Senior Scientist, Protein Engineering
Systimmune
Associate Director, Biologics Formulation Development
Dianthus Therapeutics
Senior Scientist, Immuno-Oncology
Systimmune
Senior Scientist I (Protein & Antibody Production)
Exelixis
Lead Researcher Antibody Discovery
St. Jude Children's Research Hospital
Scientist I
Xaira Therapeutics